Decheng Capital LLC Portfolio Holdings

Decheng Capital LLC

  • $356 Billion
  • Q1 2025

Decheng Capital LLC has filed its 13F form on May 07, 2025 for Q1 2025 where it was disclosed a total value porftolio of $356 Billion distributed in 27 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cg Oncology Inc with a value of $156B, Nuvation Bio Inc. with a value of $45.7B, Aardvark Therapeutics Inc with a value of $29.4B, Upstream Bio Inc. with a value of $20.1B, and Newamsterdam Pharma CO Nv Shs with a value of $15.8B.

Examining the 13F form we can see an decrease of $110B in the current position value, from $466B to 356B.

Decheng Capital LLC is based out at Menlo Park, CA

Below you can find more details about Decheng Capital LLC portfolio as well as his latest detailed transactions.

Portfolio value $356 Billion
Healthcare: $128 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
Cg Oncology Inc
-
$156 Billion 43.77% of portfolio
-
Q4 2024 Added 16.3%
$428M
$45.7 Billion 12.81% of portfolio
25,954,439
Q3 2024 Added 273.43%
Aardvark Therapeutics Inc
-
$29.4 Billion 8.25% of portfolio
-
Q1 2025 New
Upstream Bio Inc.
-
$20.1 Billion 5.64% of portfolio
-
Q4 2024 New
-
$15.8 Billion 4.42% of portfolio
-
Q4 2024 Added 30.51%
$3.4B
$11.7 Billion 3.29% of portfolio
65,000
Q1 2025 Reduced 15.33%
$3.48B
$7.99 Billion 2.24% of portfolio
226,000
Q4 2024 Added 11,200.0%
$2.44B
$7.96 Billion 2.23% of portfolio
189,098
Q3 2024 Added 5.58%
$123M
$6.97 Billion 1.96% of portfolio
4,882,651
Q4 2024 Reduced 1.52%
Moonlake Immunotherapeutics
-
$6.7 Billion 1.88% of portfolio
-
Q4 2024 Added 3.0%
$2.15B
$6.41 Billion 1.8% of portfolio
11,909,341
Q4 2024 New
$622M
$6.35 Billion 1.78% of portfolio
808,789
Q4 2024 Reduced 7.01%
$96.7M
$6.18 Billion 1.73% of portfolio
4,041,736
Q1 2025 Added 78.31%
$1.61B
$5.97 Billion 1.67% of portfolio
177,958
Q1 2025 Added 5.95%
$3.05B
$4.02 Billion 1.13% of portfolio
100,000
Q4 2024 Added 6.33%
$5.67B
$3.39 Billion 0.95% of portfolio
100,000
Q1 2025 Reduced 34.88%
$74.1M
$3.21 Billion 0.9% of portfolio
2,019,762
Q1 2025 Reduced 13.62%
$177M
$3.02 Billion 0.85% of portfolio
515,555
Q4 2023 New
$25B
$1.82 Billion 0.51% of portfolio
20,000
Q1 2025 Reduced 50.0%
$11.3M
$1.74 Billion 0.49% of portfolio
4,447,308
Q4 2023 New
$132M
$1.08 Billion 0.3% of portfolio
335,515
Q1 2025 Reduced 16.12%
$14.3B
$932 Million 0.26% of portfolio
11,749
Q1 2025 Reduced 87.6%
$41.1M
$320 Million 0.09% of portfolio
326,810
Q4 2023 New
Grail Inc
-
$247 Million 0.07% of portfolio
-
Q3 2024 Reduced 46.58%
$566M
$108 Million 0.03% of portfolio
4,495
Q1 2025 Reduced 90.97%
-
$44 Million 0.01% of portfolio
-
Q2 2024 New

Summary

  • Portfolio
  • No. of Stocks 27
  • Current Value $356 Billion
  • Prior Value $466 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 07, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 1 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Decheng Capital LLC Portfolio

Follow Decheng Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decheng Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Decheng Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email